In Trial C, fewer individuals were infected than in Trial A after six points of contact. In general, the graph's slope for Trial C was lower than that of Trial A. Compared to Trial A, the rate of infection spread was slower in Trial C. Apart from the ten individuals with immunity, three non-immune individuals remained uninfected.